The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?-Reference-Cited by-同舟云学术

The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

Published:2013-01 Issue:1 Volume:15 Page:2-8
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Galipeau Jacques

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference61 articles.

1. Good manufacturing practices production of mesenchymal stem/stromal cells;Sensebe;Hum Gene Ther,2011

2. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici;Cytotherapy,2006

3. Clarification of the nomenclature for MSC. The International Society for Cellular Therapy position statement;Horwitz;Cytotherapy,2005

4. Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency;Ren;Cytotherapy,2011

5. Treatment of graft-versus-host-disease with mesenchymal stromal cells;Kebriaei;Cytotherapy,2011

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges;Signal Transduction and Targeted Therapy;2024-09-13

2. Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications;European Journal of Pharmacology;2024-08

3. The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review;Frontiers in Cell and Developmental Biology;2024-07-26

4. New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature;Expert Opinion on Investigational Drugs;2024-07-09

5. Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice;Molecular and Cellular Biochemistry;2024-07